• UCLA Health
  • myUCLAhealth
  • School of Medicine
Center for Inflammatory Bowel Diseases

UCLA Center for Inflammatory Bowel Diseases

Center for Inflammatory Bowel Diseases
  • Back to Division of Digestive Diseases
  • About Us
  • What is IBD?
    • Ulcerative Colitis
    • Crohn's Disease
    • Ulcerative Colitis vs Crohn's Disease
  • For Patients
    • What to Bring to Your Appointment
    • Infusion Centers
    • Nutrition Program
    • Tests and Preps - GI Patients May Need
    • Make an Appointment
  • Research
    • Our Research
    • Clinical Trials and Studies
    • Research Faculty
  • News and Events
  • Make an Appointment / Refer a Patient
  • Meet the Team
  • UCLA Health
  • myUCLAhealth
  • School of Medicine

UCLA Center for Inflammatory Bowel Diseases

Research

Research

Research

  • Our Research
  • Clinical Trials and Studies
  • Research Faculty
  • Our Research
  • Clinical Trials and Studies
  • Research Faculty
  1. Home
  2. Center for Inflammatory Bowel Diseases
  3. Research
  4. Our Research

Our Research

Share this

The UCLA Inflammatory Bowel Disease Research Center, established in 2007, focuses on multiple aspects of the pathophysiology, therapy, and diagnosis of IBD with some of the funding from the National Institutes of Health (NIH), the Broad Foundation, and the Crohn's & Colitis Foundation of America, Inc. Their discoveries are not only helping to unravel the mysteries driving IBD pathogenesis at the molecular and cellular levels, but they are also providing targets for new therapeutic approaches — some of which are currently under investigation.


Research Collaboration

Research Collaborations

Clinical Research Alliance
UCLA is a member of the Clinical Research Alliance of the Crohn’s and Colitis Foundation of America. The mission of the Clinical Research Alliance is to ask and answer clinically relevant questions that would not otherwise be studied, with the ultimate goal of improving the life of patients with IBD. Learn more

Corrona Inflammatory Bowel Disease Registry
The objective of the Corrona Inflammatory Bowel Diseases (IBD) Registry is to create a national cohort of patients with Crohn's disease (CD), ulcerative colitis (UC) and indeterminate colitis (IC). Data collected will be used to better characterize the natural history of the disease and to extensively evaluate the effectiveness and safety of medications approved for the treatment of IBD. Corrona IBD Registry  |  Enroll in the Registry

Research Clinical Trial

Clinical Trials

Our center conducts cutting-edge biomedical and health-related research studies that include both interventional and observational studies View current list of clinical trials


Noam Jacob MD PhD

Jacob Laboratory

Dr. Jacob studies the mechanisms of inflammatory bowel disease (IBD) — in particular, how molecules known as cytokines influence both inflammation and fibrosis in the disease process. Jacob Laboratory

Jonathan Jacobs MD PhD

Jacobs Laboratory

Our work in the microbiome realm includes a group headed by Dr. Jonathan P. Jacobs that is investigating how the intestinal microbiome contributes to IBD development. Jacobs Laboratory


Berkeley Limketkai MD PhD

Limketkai Laboratory

The Limketkai Lab is a clinical/translational research laboratory whose mission is the generation, experimentation, and application of knowledge that can help shape and improve future care of our patients. Our key research themes -- individually and in combination -- include the domains of inflammatory bowel diseases (IBD), nutrition and biomedical innovation. Limketkai Laboratory

Harry Pothoulakis MD

Pothoulakis Laboratory

The group headed by Dr. Charalabos “Harry” Pothoulakis is internationally recognized for its work in describing how microRNAs are involved, and in developing treatment strategies that capitalize on these findings. Pothoulakis Laboratory

Harry Pothoulakis MD

Center for Systems Biomedicine

The center is focused on how the environment influences IBD pathogenesis through changes in the epigenome and microbiome. In the epigenome category, Dr. Harry Pothoulakis and his colleagues are leaders in the use of cutting-edge approaches such as systems science and artificial intelligence to discover the role of DNA methylation and histone modifications in the development of IBD. Center for Systems Biomedine


Emeran A. Mayer MD PhD

G. Oppenheimer Center for Neurobiology of Stress and Resilience

Dr. Emeran A. Mayer and his colleagues are conducting pioneering studies exploring the interactions between IBD and the nervous system, amid mounting interest in the role of brain alterations in IBD pathogenesis. G. Oppenheimer Center for Neurobiology of Stress and Resilience

Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest
UCLA Health hospitals ranked best hospitals by U.S. News & World Report
  • UCLA Health
  • Find a Doctor
  • School of Medicine
  • School of Nursing
  • UCLA Campus
  • Directory
  • Newsroom
  • Subscribe
  • Patient Stories
  • Giving
  • Careers
  • Volunteer
  • International Services
  • Privacy Practices
  • Nondiscrimination
  • Billing
  • Health Plans
  • Emergency
  • Report Broken Links
  • Terms of Use
  • 1-310-825-2631
  • Maps & Directions
  • Contact Us
  • Your Feedback
  • Report Misconduct
  • Get Social
  • Sitemap
Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest

Sign in to myUCLAhealth